230 related articles for article (PubMed ID: 26621248)
1. Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance.
Liepinsh E; Makrecka-Kuka M; Makarova E; Volska K; Svalbe B; Sevostjanovs E; Grinberga S; Kuka J; Dambrova M
Pharmacol Res; 2016 Nov; 113(Pt B):788-795. PubMed ID: 26621248
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of L-carnitine biosynthesis and transport by methyl-γ-butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction.
Liepinsh E; Makrecka-Kuka M; Kuka J; Vilskersts R; Makarova E; Cirule H; Loza E; Lola D; Grinberga S; Pugovics O; Kalvins I; Dambrova M
Br J Pharmacol; 2015 Mar; 172(5):1319-32. PubMed ID: 25363063
[TBL] [Abstract][Full Text] [Related]
3. Acute and long-term administration of palmitoylcarnitine induces muscle-specific insulin resistance in mice.
Liepinsh E; Makrecka-Kuka M; Makarova E; Volska K; Vilks K; Sevostjanovs E; Antone U; Kuka J; Vilskersts R; Lola D; Loza E; Grinberga S; Dambrova M
Biofactors; 2017 Sep; 43(5):718-730. PubMed ID: 28759135
[TBL] [Abstract][Full Text] [Related]
4. Decrease in Long-Chain Acylcarnitine Tissue Content Determines the Duration of and Correlates with the Cardioprotective Effect of Methyl-GBB.
Kuka J; Makrecka-Kuka M; Cirule H; Grinberga S; Sevostjanovs E; Dambrova M; Liepinsh E
Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):106-112. PubMed ID: 28244203
[TBL] [Abstract][Full Text] [Related]
5. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
[TBL] [Abstract][Full Text] [Related]
6. AMPK-α2 is involved in exercise training-induced adaptations in insulin-stimulated metabolism in skeletal muscle following high-fat diet.
Abbott MJ; Turcotte LP
J Appl Physiol (1985); 2014 Oct; 117(8):869-79. PubMed ID: 25103967
[TBL] [Abstract][Full Text] [Related]
7. The impact of altered carnitine availability on acylcarnitine metabolism, energy expenditure and glucose tolerance in diet-induced obese mice.
Schooneman MG; Houtkooper RH; Hollak CE; Wanders RJ; Vaz FM; Soeters MR; Houten SM
Biochim Biophys Acta; 2016 Aug; 1862(8):1375-82. PubMed ID: 27112275
[TBL] [Abstract][Full Text] [Related]
8. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
9. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
[TBL] [Abstract][Full Text] [Related]
10. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
[TBL] [Abstract][Full Text] [Related]
11. Plasma acylcarnitine profiling indicates increased fatty acid oxidation relative to tricarboxylic acid cycle capacity in young, healthy low birth weight men.
Ribel-Madsen A; Ribel-Madsen R; Brøns C; Newgard CB; Vaag AA; Hellgren LI
Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27694528
[TBL] [Abstract][Full Text] [Related]
12. A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice.
Jeong HW; Lee JW; Kim WS; Choe SS; Shin HJ; Lee GY; Shin D; Lee JH; Choi EB; Lee HK; Yon GH; Cho B; Kim HR; Choi SH; Chung YS; Park SB; Chung H; Ro S; Kim JB
Mol Pharmacol; 2010 Nov; 78(5):877-85. PubMed ID: 20724462
[TBL] [Abstract][Full Text] [Related]
13. Amodiaquine improves insulin resistance and lipid metabolism in diabetic model mice.
Jung HY; Kim B; Ryu HG; Ji Y; Park S; Choi SH; Lee D; Lee IK; Kim M; Lee YJ; Song W; Lee YH; Choi HJ; Hyun CK; Holzapfel WH; Kim KT
Diabetes Obes Metab; 2018 Jul; 20(7):1688-1701. PubMed ID: 29516607
[TBL] [Abstract][Full Text] [Related]
14. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.
Finck BN; Bernal-Mizrachi C; Han DH; Coleman T; Sambandam N; LaRiviere LL; Holloszy JO; Semenkovich CF; Kelly DP
Cell Metab; 2005 Feb; 1(2):133-44. PubMed ID: 16054054
[TBL] [Abstract][Full Text] [Related]
15. A novel recombinant peptide INSR-IgG4Fc (Yiminsu) restores insulin sensitivity in experimental insulin resistance models.
Wang J; Shi Z; Zou T; Zou MX; Yang HX; Zhang CP; Xiang DB; Lin LM; Liu HY; Fang DY; Liao DF
Biomed Pharmacother; 2019 Jan; 109():1276-1286. PubMed ID: 30551378
[TBL] [Abstract][Full Text] [Related]
16. Hemin Improves Insulin Sensitivity and Lipid Metabolism in Cultured Hepatocytes and Mice Fed a High-Fat Diet.
Luan Y; Zhang F; Cheng Y; Liu J; Huang R; Yan M; Wang Y; He Z; Lai H; Wang H; Ying H; Guo F; Zhai Q
Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933767
[TBL] [Abstract][Full Text] [Related]
17. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
[TBL] [Abstract][Full Text] [Related]
18. Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway.
Yu D; Ye X; Wu Q; Li S; Yang Y; He J; Liu Y; Zhang X; Yuan Q; Liu M; Li D; Ren G
Endocrine; 2016 Jun; 52(3):527-40. PubMed ID: 26607153
[TBL] [Abstract][Full Text] [Related]
19. Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.
Zhang J; Light AR; Hoppel CL; Campbell C; Chandler CJ; Burnett DJ; Souza EC; Casazza GA; Hughen RW; Keim NL; Newman JW; Hunter GR; Fernandez JR; Garvey WT; Harper ME; Fiehn O; Adams SH
Exp Physiol; 2017 Jan; 102(1):48-69. PubMed ID: 27730694
[TBL] [Abstract][Full Text] [Related]
20. Methyl-γ-butyrobetaine decreases levels of acylcarnitines and attenuates the development of atherosclerosis.
Vilskersts R; Kuka J; Liepinsh E; Makrecka-Kuka M; Volska K; Makarova E; Sevostjanovs E; Cirule H; Grinberga S; Dambrova M
Vascul Pharmacol; 2015 Sep; 72():101-7. PubMed ID: 25989106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
